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SUMMARY
This paper determines the influence of
physical parameters of intracavitary irradiation,
such as the length of the intrauterine tube, the
size of vaginal ovoids, the distance between
them and the arrangement of the active sources
in the ovoids, on the physicał dose at reference
points in the bladder and rectum. The biological
equivalence of irradiation with the use of the
Selectron LOR in relation to the Manchester
method, with reference to early and late
reactions were calculated on the basis of the L-
Q model.
INTRODUCTION
Intracavitary irradiation allows administration
of a sufficient dose to the neoplasmatic tumour,
but on the other hand, leads to a considerable
exposure to radiation of the critical organs such
as rectum and bladder. The knowledge of the
influence of physical parameters of irradiation
on the dose at reference points, makes it
possible to optimize the dose distribution, in
such a way that the administration of the
planned dose at point A would not be
associated with the excess of the tolerance
dose in the rectum and bladder. The physical
parameters of the irradiation with the Selectron
LOR were defined according to the modified
Manchester method used in our Clinic for over
30 years, in which radium was replaced by 13.5
mm long caesium - 137 sources filtrated by 0.5
mm Pl. (Lewocki, 1994) The influence of the
length of the intrauterine tube and the size of
active sources in the ovoids on the physical
dose at reference points was analysed.
Intrauterine applications were performed with
the use of standard applicators and caesium -
137 sources of the nominał activity of 40 mGi.
The correction of the total dose associated with
higher activity of the Selectron sources was
calculated using the L-Q model.
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MATERIAL AND METHOD
In order to perform intracavitary irradiation with
Selectron LOR, a selectron standard applicators
set has been used. Positioning of the sources in
the applicators has been determined
experimentally on the basis of the analysis of
the isodose curves and the dose at point A. The
long intrauterine tubes contains 7 radioactive
spherical sources in positions 1,3,5,8,13,16,21.
In each vaginal ovoid 2.5 mm in diameter, four
sources were placed in positions 3.4,6,7. The
remaining positions contain dummy sources.
For this set of applicators, the dose rate at point
A is 1.67 Gy/h. The dose of 75 Gy is obtained at
this point in 45 hours. In the medium uterine
tube, the active sources are placed in position
1,3,5,8,13. (Lewocki, 1994)
Since all sources have the same activity, the
differences in the quantity of radiumused in the
classical Manchester method, associated with
the size of vaginal ovoids, were replaced by
different times of irradiation. The correction of
the irradiation times correlated with the different
size of the ovoids, was calculated on the basis
of the ratios of the radium sources used in the
Manchester method. (Tab.1)
Type ot ovoid Number ot mg radium in Time correction factors
c1assical Manchesler in irradiation for
method Selectron
Smalleslovoid 15,0 mo 0,75
Smali ovoid 17,5 mo 0,875
Medium ovoid 20,0 mo 1
Lame ovoid 22,5 mo 1,125
Table 1. Time correction factors for Selectron
irradiation equal activity sources depending on the
ovoid size.
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THE BIOLOGICAL EQUIVALENCE OF
IRRADIATION USING THE MODIFIED
MANCHESTER METHOD WITH SELECTRON
LDR
The linear - quadratic model L-Q was used to
calculate the biologically equivalent dose
administered in the modified Manchester
method employing Selectron (Barendsen,
1982).
ERDc =De ( 1+2r/a/l3 ),
where r is the dose rate in Gy/h, and Oc is the
total dose during continuous irradiation.
This equation can be applied on the
assumption that the Ume of application is much
longer than the sublethal damage repair half-
times, Le, 1.5 - 2 hours. According to some
authors, the values of the ERDc ( Extrapolated
Response Dose in continuos irradiation ) are
calculated (Barendsen, 1982; Fowler, 1989),
assuming that the all3 ratio is 10 for early
reacting tissues and the tumour, and 3 for late
reacting tissues. The equivalent doses for the
early reacting tissues and the tumour are shown
in Table 2, and these for late responding tissues
in Table 3.
Mełhod of irradiation
Modilied Manchester method Selectron, dose rate = 1,67 Decrease in
dose rate = 0,535 Gylh Gy/h physical dose
[%1
D(A) rGvl(1) ERDc(2) D(A) rGv1 ERDc
75,0 77,5 62,25 77,5 17 %
60,0 66,44 49,82 66,44 17%
55,0 60,9 45,66 60,9 17%
50,0 55,32 41,52 55,32 17%
Table 2 Biological equivalence for acute radiation
reaction ofthe tissues and tumour responsea/f3=10.
(1) D(A) - dose in point A, (2) ERDc - extrapolated
response dose during continuous irradiation.
The analysis of the physical parameters of
irradiation with the modified Manchester method
using Selectron was based on c1inical data
comprising 126 gynaecological brachytherapy
applications. The reference point doses were
normalised to the dose of 75 Gy at point A, and
than compared. Table 4 illustrates the dose at
point A which in the applications performed with
Selectran is 3.2 % greater than that in the
applications performed with the modified
Manchester method. The mean absorbed dose
at this point, calculated for the graup of 126
applications is 77.4 Gy. The deviation fram the
mean calculated value is 6.5 % (5.03 Gy).
Method ol irradiation
Modified Manchester method trradlation with Selectron
Reference Reference Equivalent Physical Decreas
points dose dosa by dose e in
ERDc(1) [Gy] physical
a1p=10 dose
["lo]
PointA 75,0 Gy 77,4 Gy 64,2 Gy 13,5 %
Point i3 22,1 Gy 22,5 Gy 19,41 Gy 12,2 %
Lymph
nodes
External iliac 14,4 Gv 15,3Gy 12,7Gy 11,8%
Commoniliac 10,1 Gv 11,0 Gv 9,2 Gv 8,9%
Para-aortic 3,2 Gv 3,4 Gv 2,9Gv 9,4 %
Table 4. The doses at reference points in
conventional intracavitary irradiation with a modified
Manchester method and by Selectron. (1) ERDc -'
Extrapolated response dose in continuous irradiation,
The bladder and rectum reference points doses
were 97.2% ± 33.7% and 68.4% ± 31.9 %,
respectively, in relation to the dose at point A.
The influence of the length of the uterine tube on
the dose at point A, as well as in the rectum and
bladder, was also estimated (Fig. 1).
Fig.1. The doses at reference points depending on
the length of the intrauterine probe.
Method ar irradiation
Modified Manchester 5electron, dose rate Oecrease in
Method dose rate = 1,67 Gylh physical dose
= 0,535 Gvlh [%]
DlA) rGvl ERDc DlA) rGvl ERDc
75,0 95,02 48,23 95,02 35,7 %
60,0 81,44 38,58 81,44 35,7%
55,0 74,66 35,36 74,66 35,7%
50,0 67,86 32,14 67,86 35,7 %
Table 3 Biological equivalence for late radiation
reaction of the tissues a/f3 = 3. (1) D(A) - dose at
point A, (2) ERDc - extrapolated response dose
during continuous irradiation.
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The doses were normalised to a model
application with the use of a long uterine tube,
which was also the basis to calculate the table
of application times, when irradiating using
Selectron. Fig. 1 shows that the length of the
intrauterine tube has no significant influence on
the dose at point A. The highest dose at the
bladder reference point was observed using the
4 cm long uterine tube (113.7 %) and the lowest
dose using 6 cm long tube (96.4%). Similarly, at
the rectum reference point the highest dose was
observed when the 4 cm long tube was used
(77.2 %), and the lowest dose when the 6 cm
long tube was used (68.1 %).
The mean doses calculated at point A, and
those in the bladder and rectum, were
normalised to the dose at point A in the model
application, where the ovoids of different size
were used (Fig.2).
0.5 cm 1.0 cm 1.5 cm .2.0 cm
Distance between ovoids
Fig.2. The doses at reference points depending on
the size of the ovoids.
The highest dose at point A was obtained using
large oVoids ( 104.3 % ), and the lowest dose-
using smali ovoids ( 88.4 % ). At the bladder
reference point, the highest dose was observed
when smali ovoids were applied (114 %),
whereas the smallest dose was found for
medium size ovoids. At the rectum reference
point, the dose increased from 64.4 % when
smali ovoids were used, to 74.5 % for large
ovoids.
The impact of the position of active sources in
the ovoids on the doses at point A, the bladder
and rectum reference points was estimated. The
dose at point A in the application with the use of
a long intrauterine tube and the ovoids
containing active sources in positions 3,4,6,7
was estimated to be 100%. It was a typical
configuration of active sources in the ovoids
used in our Clinic. The results shown in Fig. 3
indicate that the most favourable dose
distribution in the rectum was obtained with the
location of active sources in positions 3,4,6,7.
However, this occurs at the cost of a greater
burden to the bladder. Ali other configurations of
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active sources in the ovoids increases the dose
in the rectum and diminishes the dose in the
bladder.
On the basis of the model application, the
dependence ot the dose at point A and rectum
on the distance between the ovoids was
established. The rectum reference point was
defined at the distance ot 0.5 cm trom the
posterior surface ot the ovoids. The dose at
point A in the application with the use of a long
intracavitary tube and the medium size ovoids
spaced 1 cm apart, was defined as 100 %. Fig.
3 indicates that an increase in the distance
between the ovoids by 0.25 cm decreases the
dose in the rectum by about 3 %. The distance
between the ovoids has practically no influence
on the absorbed dose at point A.
Type ot intrauterine tube
Fig.3. The doses at reference points depending on
the positioning of the sources in the ovoids.
DISCUSSION
Physical doses which should be administered
with Selectron in order to obtain the same
biological equivalence of irradiation as that with
the modified Manchester method, were
calculated using the ERD equation. The same
ERD values for early reactions (af/3=10) were
obtained with the reduction of the physical dose
by 17%, whereas for the late reactions (a/j3=3)
the reduction of 36% was necessary. The use ot
the 17% correction of the physical dose when
calculating the time of irradiation with Selectron
can be justified by the following explanation:
- c1inical experience of some authors
(Akine et al., 1980;Hunter, 1985; Hunter, 1992)
shows that by applying a dose-rate of 1.5-1.8
Gy/h to point A during intracavitary irradiation
similar results of the treatment are achieved, as
those using the Manchester method, when the
physical dose is reduced by 10 - 20%,
- the vaginal tamponing during the
application effectively moves the rectum away
trom the vaginal ovoids. In this way, the· dose in
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the rectum and the risk ot late effects in this
organ can greatly be reduced,
- although in later years attention was
drawn to the lack ot correlation between the
early and late reactions in some organs
including the rectum, this correlation has been
confirmed by several clinical studies and cellular
models (Klimek, 1993).
The dependence ot the dose at point A and
that in the bladder and rectum reterence points
upon such parameters as the length ot the
intrauterine tube the size ot the ovoids, the
distance between them and the arrangement ot
active sources in the ovoids was analysed. A
very smali influence ot these parameters on the
dose at point A was tound, whereas the
exposure ot the bladder and the rectum c1early
depends on the size ot the ovoids and the
distance between them. Untavourable
anatomical conditions in the vagina, which allow
only the insertion ot the smali and smallest
ovoids, cause an increase in the dose in the
bladder and rectum. The possibility ot an
individualised optimisation ot the dose
distribution by different arrangement ot active
sources in the ovoids, permits administration ot
a lower dose to these organs. The analysis ot
some aspects ot the dosimetry during irradiation
with Selectron, was carried out by Szymczyk et
al. [8]. In their study, experimental configuration
ot active sources in the applicators was similar
to that applied in our own study. The mean dose
in the rectum (52%) in relation to the dose at
point A was lower than that in our study (68.4%).
This is probably due to the employiment ot a
different method ot defining the dose in the
rectum. The intluence ot the distance between
the ovoids on the dose in the rectum shown by
Szymczyk et al. to be a line ot regression, is
similar to our results presented in Fig. 4. Similar
results were also obtained in relation to the most
tavourable arrangement ot active sources in the
vaginal ovoids.
120%
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Position ot pellets
FigA. The doses at reference points depending on
the distance between ovoids.
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CONCLUSIONS
1. The L-Q model can be a usetul tool tor the
estimation ot a biologically equivalent dose in
intracavitary irradiation performed with different
dose rate sources.
2. The knowledge ot the influence ot physical
parameters ot intracavitary irradiation on the
dose ot reterence points permits optimisation ot
the dose distribution in such a way that the
administration ot the planned dose at point A
would not be associated with the excess ot the
tolerance dose in the rectum and bladder.
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